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Peroxiredoxin I (Prx I) is a member of the peroxiredoxins (Prxs) family, which are antioxidant enzymes
that regulate various cellular process via intracellular oxidative signal pathways. In order to investigate the
correlation between Prx I and the γ-secretase complex, which causes Alzheimer’s disease (AD), the
expression level of Prx I was firstly evaluated in an animal model for AD. NSE/hPen-2 transgenic (Tg)
mice, which were used as animal model in this study, showed a high level of Pen-2 expression and
accumulation of Aβ-42 peptides in the hippocampus of brain. The expression level of Prx I was
significantly higher on the mRNA and protein level in the brain of this model, while not change in Prx VI
expression was observed. Furthermore, to verify the effect of Prx I on the γ-secretase components in vitro,
the expression level of these components was analyzed in the Prx I transfectants. Of the components of
the γ-secretase complex, the expression of PS-2 and Pen-2 was lower in the transfectants overexpressing
Prx I compared to the vector transfectants. However, the expression of APP, NCT and APH-1 did not
change in Prx I transfectants. Therefore, these results suggested that the expression of Prx I may be
induced by the accumulation of Aβ-42 peptides and the overexpression of Prx I in neuroblastoma cells
may regulate the expression of γ-secretase components.
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Peroxiredoxins (Prxs) are a 24-kDa peroxidase that belongs
to an antioxidant enzyme family. The cysteine (Cys) residue
on this protein is the primary site of oxidation and acts as
an electron donor for the reduction of peroxides [1,2]. Six
isoforms of mammalian Prxs (I-VI) were identified with similar
immunological properties and amino acid sequences [3,4].
The distribution of the Prxs isoforms in the human brain
was found to vary. Prx I was primarily expressed in astrocytes,
while Prx II was expressed in neurons of various region
including the cerebral cortex, hippocampus, cerebellum, basal
ganglia, substantia and spinal cord. Moreover, they were
differentially located within cells. Prx I, II and VI were mainly
distributed to the cytosol, but Prx III and V were largely present
in the organelles and Prx IV was secreted into the extracellular
region [5,6].
Of the six isoforms, Prx I was predominantly expressed
in various type of tumors and functioned as an anti-apoptotic
protein for tumor cells proliferation and survival [2]. In addition,
several studies have found that Prx I was tightly correlated
with neurodegenerative disease [7,8]. The expression level
of Prx I was not significantly altered in Down syndrome (DS),
Alzheimer’s disease (AD) and Pick’s disease (PD) when
compared to the control [7]. Especially, AD which was showed
the massive accumulation of extracellular Aβ-42 peptides
produced by γ-secretase composing of four subunits and the
hyperphosphorylation of Tau proteins has been received great
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interest from scientists [9,10]. The Aβ-resistance PC12 cell
line showed higher expression levels of multiple Prxs isoforms
than that of the control cells with reduced cysteine oxidation.
Furthermore, an increase in Aβ-resistant was induced by
transfection of wild type Prx I in PC12 cells and rat primary
hippocampal neurons [8]. However, the effects of Prx I on
the expression of the γ-secretase complex on AD have not
yet been studied and are unknown. Therefore, in this study,
we investigated whether Prx I could regulate the expression
of the γ-secretase complex, which causes AD, in cells
overexpressing Prx I and an AD animal model.
Materials and Methods
Care and use of animals
The animal model for AD was produced by the
microinjection of the human Pen-2 gene, a key regulator
of γ-secretase complex, into the pronucleus of fertilized eggs
as described previously [11]. All animal experimental
procedures were approved by the Institutional Animal Care
and Use Committee (IACUC) at the Pusan National University
(Approval No.: PNU-2010-000220). All mice were supplied
by the breeding center of Korea FDA facility and were housed
in cages under a strict light cycle (lights on at 06:00 h and
off at 18:00 h) and constant temperature of 23±1
oC. In
addition, all mice were provided a standard irradiated chow
diet (Purina Mills, St. Louis, MO, USA) ad libitum and
maintained in a specific pathogen free (SPF) state.
Reverse transcription-polymerase chain reaction
(RT-PCR) analysis in tissue of Tg mice
For the preparation of total RNA, tissues frozen in liquid
nitrogen were chopped with scissors and homogenized in
a RNA-Bee
TM solution (Tel-Test, Austin, TX, USA). The isolated
RNA was then quantified using an Ultraspec 1000 system
(Amersham Pharmacia Biotech, Buckinghamshire, UK). To
characterize the expression of transgenes, RT-PCR was
conducted using 5 µg of total RNA from each of the tissue
samples. 500 ng of Oligo-dT primer (Invitrogen, Carlsbad,
CA, USA) was annealed for 10 min at 70
oC. Complementary
DNA, which was utilized as a template for further amplification,
was synthesized via the addition of dATP , dCTP , dGTP and
dTTP , as well as 200 units of reverse transcriptase. In these
reactions, 10 pmoles of the sense and antisense primers were
added, and the reaction mixtures were subjected to 30 cycles
of amplification. Amplification was conducted in the
aforementioned thermal cycler under the following conditions:
30 sec at 94
oC, 30 sec at 62
oC and 45 sec at 72
oC. In
each case, minus-RT controls were included to distinguish
between the DNA and RNA products. This experiment was
repeated three times, and the relative differences in RNA
quantity were also reproducibly observed in the three
experiments. The sequences of the sense and antisense primers
for Pen-2 were 5’-GCTAT GAACC TGGAG CGAGT G-3’
and 5’-GAAGG AGAGG TAGTC CCCAA GG-3’, Prx I were
5’-GCGCT AGCGG ACTGC TGATA GGAAG ATGTC-3’ and
5’-GCCTC GAGCA GCGCT CACTT CTGCT TGGAG-3’, Prx
VI were 5’-GCGCT AGCCT TGTTC TCAGC GTCAC CACTG
-3’ and 5’-GCCTC GAGCC AGTAC TGGAT GTGCA GATGC
AG-3’,  β-actin were 5’-TGGAA TCCTG TGGCA TCCAT
GAAAC-3’ and 5’-TAAAA CGCAG CTCAG TAACA GTCCG-
3’, respectively. Finally, the levels of each Pen-2, Prx I and
Prx VI RT-PCR product were quantified using the
aforementioned electrophoresis documentation and analysis
system on a 1% agarose gel.
Western blotting
SH-SY5Y cells harvested from 100 mm-diameter culture
dishes and the tissue from non-Tg and NSE/hPen-2 Tg mice
were solubilized and homogenized with 1% nonidet P-40
in 150 mM NaCl, 10 mM Tris HCl (pH 7.5), and 1 mM EDTA,
and supplemented with a protein inhibitor mixture (Roche,
Basel, Switzerland). From 15 to 30 µg of protein was separated
by electrophoresis on a 10% polyacrylamide gel for 2 h and
the resolved species were transferred to a nitrocellulose
membrane by electroblotting for 2 h. The membrane was
incubated with primary anti-human Pen-2 antibody (Santa
Cruz Biotechnology, Santa Cruz, CA, USA, 1:1,000 dilution),
anti-PS-2 antibody (Cell Signaling Technology, Boston, MA,
USA, 1:1,000 dilution), anti-APP antibody (Sigma-Aldrich, St.
Louis, MO, USA, 1:4,000 dilution), anti-APH-1 antibody
(Sigma-Aldrich, 1:1,000 dilution), anti-NCT antibody (Cell
Signaling Technology, 1:1000 dilution), anti-Prx I antibody
(Abcam, Cambridge, UK, 1:1000 dilution), anti-Prx VI antibody
(Abcam, 1:1000 dilution) or anti-actin antibody (Sigma-
Aldrich, 1:3,000 dilution) overnight at 4
oC. Each membrane
was washed with buffer (137 mM NaCl, 2.7 mM KCl, 10 mM
NaHPO4, and 0.05% Tween-20) and incubated with a 1:1,000
dilution of horseradish peroxidase (HRP)-conjugated goat anti-
rabbit IgG at room temperature for 2 h. The membrane blots
were developed using Enhanced Chemiluminescence Reagent
Plus kit (Amersham).
Perfusion and immunohistochemcal analysis
Brain perfusion and immunohistochemical analyses was
performed as previously described [12,13]. Briefly, mice were
anaesthetised with Zoletil 50 (Virbac, Carros cedex, France)
and transcardially perfused with 1X PBS followed by 4%Effect of peroxiredoxin I on the expression of γ-secretase complex 295
Lab Anim Res | December, 2011 | Vol. 27, No. 4
formaldehyde to effectively remove the blood and fix the
brain tissue. After perfusion, each mouse brain was isolated
from the skull and fixed overnight in formaldehyde. Each
brain was dehydrated and embedded in paraffin. A series
of brain sections (10 µm) were cut from paraffin-embedded
tissue using a Leica microtome (Leica Microsystems,
Bannockbrun, IL, USA). For immunohistochemical analysis,
these sections were de-paraffinized with xylene, rehydrated
and pretreated for 30 min at room temperature with PBS
blocking buffer containing 10% goat serum. The sections were
then incubated with the anti-Aβ-42 antibody (Invitrogen), at
a dilution of 1:100 in PBS blocking buffer. The antigen-antibody
complexes were visualized with biotinylated secondary
antibody (goat anti-rabbit)-conjugated HRP streptavidin
(Histostain-Plus Kit; Zymed, South San Francisco, CA, USA),
at a dilution of 1:1,500 in PBS blocking buffer. The Aβ-42
peptides were detected using stable 3,3’-diaminobenzidine
(DAB; Invitrogen) and observed using a model BX50F-3 optical
microscope (Olympus, Tokyo, Japan).
Gene constructions
The CMV/hPrx I plasmid, which harbors hPrx I under the
control of the CMV promoter, was constructed. Briefly, the
hPrx I gene (GenBank accession No. BC021683.1) was
amplified by the PCR using a full-length RNA isolated from
NCI-H460 human carcinomal cells. The primers used for
the amplification were hPrx I sense primer, 5’-GCgctagc
GGACT GCTGA TAGGA AGATG TC-3’ (italic letter, NheI
site; ATG, start codon; capital letter, hPrx I  sense primer
corresponding to nucleotides 57-78 of hPrx I) and the hPrx
I anti-sense primer, 5’-GCctcgag  CAGCG CTCAC TTCTG
CTTGG AG-3’ (italic letter, XhoI site; the capital letter
corresponds to nucleotides 658-679 of hPrx I). The primers
used contained a recognition sequence for the NheI and
XhoI enzymes at the 5’ and 3’ end of the PCR products,
respectively. The amplified hPrx I was 622-bp in length, and
the product was cloned into the T cloning vector (pGEM-
T; Promega, Madison, WI, USA). Sequence analysis was
conducted in order to confirm whether or not the cloned
hPrx I sequence was identical to hPrx I cDNA, and the resulting
sequence was aligned with the NCBI sequence database,
using the BLAST program to identify their corresponding hPrx
I gene. The hPrx I cDNA fragment isolated using NheI and
XhoI digestion was inserted into the pEGFP-C1 vector in order
to construct the CMV/hPrx I recombinant vector. Finally, the
CMV/hPrx I plasmid was subjected to enzyme digestion and
automatic sequence analysis to confirm their sequence and
orientation (Figure 3A).
Cell cultures and DNA transfection
NCI-H460 cells and SH-SY5Y cells were purchased from
the Korean Cell Line Bank (Seoul, Korea). Cells were grown
in monolayers in RPMI 1640 (Hyclone Co., Logan, UT, USA)
supplemented with 10% fetal bovine serum (FBS; Invitrogen)
and antibiotics (100 unit/mL penicillin and 100 µg/mL
streptomycin; Invitrogen) during incubation at 37
oC in a
Figure 1. Pen-2 expression and accumulation of Aβ-42
peptides in the brain of CMV/hPen-2 Tg mice. (A) Brain specific
expression of the hPen-2 transgenes in the Tg mice by RT-
PCR. The β-actin signal was used as the control, and the
transcript (640-bp) indicates RNA loading. In addition, the RT-
PCR products for hPen-2 (284-bp) are indicated. The density of
the amplified transcripts was quantified. (B) Immunostaining
analysis of the Aβ-42 peptides. The brains were taken from
NSE/hPen-2 Tg mice and Non-Tg mice after perfusion. The
level of the Aβ-42 peptide was detected in the immunostaining
analysis using an Aβ-42 specific antibody. A high intensity was
observed in the hippocampus of the NSE/hPen-2 Tg mice
when compared with the Non-Tg mice at 200x magnification.
The data represents the mean±SD from three replicates.
*P<0.05; significant difference between NSE/hPen-2 Tg and
Non-Tg mice.296 Young Ju Lee et al.
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humidified incubator containing 5% CO2 in air. All other
chemicals were purchased from Sigma-Aldrich. To overexpress
the Prx I protein in neuroblastoma cells, the cells were
transfected with the CMV/hPrx I plasmid using the
Lipofectamine
TM Reagent (Invitrogen). SH-SY5Y cells were
seeded at a density of 2×10
6 cells per 100 mm-diameter
dish. After reaching 80-90% confluence, a plasmid-
lipofectamine mixture containing 20 µg of DNA (per dish)
was added, and the cells were incubated for an additional
5h  a t  3 7
oC in OptiMEM medium. The cells were then cultured
in fresh serum-free medium for 24 h and were used for
Western blot and flow cytometry analyses.
Statistical analysis
Tests for significance were conducted using one-way
ANOVA analyses of variance (SPSS for Windows, Release
10.01; SPSS, USA). All values were expressed as the mean
±standard deviation (SD). Standard significance was set as
a value of P<0.05.
Results
Accumulation of Aβ-42 peptides in the brain of
NSE/hPen-2 Tg mice
Remarkable accumulation of Aβ-42 peptides is one of most
important features in the animal model for AD [12]. Pen-
2 expression was first detected using RT-PCR analysis. The
mRNA expression of Pen-2 was dramatically higher in the
brain of NSE/hPen-2 Tg mice (Figure 1A). In order to investigate
the accumulation of Aβ-42 peptides in the brain of NSE/
hPen-2 Tg mice, the level of Aβ-42 peptides was detected
by immunohistochemical analysis. NSE/hPen-2 Tg mice
contained higher levels of Aβ-42 peptides in the hippocampus
of brain than the Non-Tg mice (Figure 1B). Therefore, the
NSE/hPen-2 Tg mice used in this study had the distinct features
of AD.
Change of Prx I and VI expression in the brain of
NSE/hPen-2 Tg mice
Next, to investigate whether accumulation of Aβ-42 peptides
could alter Prx I and VI expression, the Prx I and VI mRNA
and protein levels were detected in the brain of Non-Tg mice
and NSE/hPen-2 Tg mice. The expression level of Prx I mRNA
was significantly higher in NSE/hPen-2 Tg mice compared
to Non-Tg mice, while the expression level of Prx VI was
not different between the two groups (Figure 2A). Also, the
protein and mRNA levels of both enzymes were very similar,
although the ratio was different in each analysis (Figure 2A).
These results suggested that accumulation of Aβ-42 peptides
induced by Pen-2 overexpression may upregulate Prx I but
not Prx VI.
Effect of Prx I overexpression on the expression of
γ-secretase complex
To study the effect of Prx I on the expression of the γ-
secretase complex, SH-SY5Y neuroblastoma cells were
Figure 2. Expression of Prx I and VI mRNA and protein in the brain of NSE/hPen-2 Tg and Non-Tg mice. (A and B) Total RNA was
purified from the whole brain of both mice, and the gene expression of the Prx I and VI were detected by RT-PCR. The β-actin
signal was used as the control, and the transcript (640-bp) indicates the RNA loading. (C and D) Total tissue lysates were prepared
from the brain tissue of NSE/hPen-2 Tg and Non-Tg mice as described in the Materials and Methods sections. Fifty micrograms of
protein per sample were immunoblotted using antibodies for each protein. Three samples were assayed in triplicate via Western
blotting. The values are expressed as the means±SD. *P<0.05; significant difference between NSE/hPen-2 Tg and Non-Tg mice.Effect of peroxiredoxin I on the expression of γ-secretase complex 297
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transfected with the CMV/hPrx I plasmid and the expression
level of each component from γ-secretase was detected using
the specific antibody. The expression level of Prx I was
successfully increased in the CMV/hPrx I transfectants when
compared to the vector transfectants. In addition, the
expression level of APP , which is a substrate of γ-secretase,
was slightly higher in the CMV/hPrx I transfectants than the
vector transfectants. Of the different components of the γ-
secretase complex, the expression level of key factors including
PS-2 and Pen-2 was lower in the CMV/hPrx I transfectants
when compared to the vector transfectants, while the
expression level of the assistant factor (APH-1 and NCT) was
higher in the CMV/hPrx I transfectants. These results suggested
that Prx I may down-regulate PS-2 and Pen-2 and up-regulate
APH-1 and NCT of the γ-secretase complex.
Discussion
Prx I is a member of the 2-Cys subfamily and is considered
a candidate therapy target of lung adenocarcinoma since
overexpression of Prx I has been observed in various cancer
cell lines [14,15]. However, most of studies have focused
Figure 3. Effects of the overexpression of Prx I on the component expression of γ-secretase complex in SH-SY5Y cells. (A)
Construction of CMV/hPrx I plasmid. The pCMV/hPrx I harbors the cDNA encoding hPrx I under the control of the CMV gene
promoter. (B and C) Total cell lysates were prepared from SH-SY5Y cells transfected with CMV control vector and CMV/hPrx I
vector as described in the Materials and Methods section. Fifty micrograms of protein per sample were immunoblotted using
antibodies for each protein. Three samples were assayed in triplicate via Western blotting. The values were expressed as
means±SD. *P<0.05 is the significance level compared to the vehicle-treated group.298 Young Ju Lee et al.
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on the role of Prx I in the development, progression and
drug resistance of cancer [14,16]. Only a few studies have
examined the correlation between Prx I and neuro-
degenerative diseases. In this study, we demonstrated that
Prx I could regulate the expression of key molecules responsible
for neurodegenerative diseases.
Especially, the expression level of PS-1 protein, a component
of the γ-secretase complex, was strongly correlated with
oxidative stress. In both the cells lysate and lipid raft fraction
of neuroblastoma SH-SY5Y cells, a significant increase in PS-
1 protein expression was observed in cells subjected to
oxidative stress; however, under the same conditions, no
changes in the expression of NCT, APH-1, Pen-2 or BACE-
1 were observed. Furthermore, this increase in PS-1 protein
expression was prevented by co-treatment with an antioxidant
[17]. In this study, an antioxidant condition was induced by
transfection of CMV/hPrx I vector, which altered the expression
level of γ-secretase complex components. As shown in Fig.
3, the expression level of the NCT and APH-1 protein was
significantly increase by the overexpression of Prx I. However,
PS-2 and Pen-2, which is a coregulator of γ-secretase activity,
was higher under the same condition. Therefore, our results
showed that the expression level of the γ-secretase complex
components may be altered by oxidative stress conditions
as well as the overexpression of antioxidant enzymes.
Several studies had provided conflicting results on the
expression levels of Prxs in the brain of AD. In a study that
examined Prxs expression in three neurodegenerative diseases,
Down syndrome (DS), AD and Pick’s disease (PD), the
expression level of Prx I under the disease condition were
reported to not be significantly different from the control.
However, the expression level of Prx II was found to be
dramatically higher in the frontal cortex for these three diseases,
where Prx III expression was lower in same region of DS
and PD [7]. Similar results were observed in Tg mice
overexpression Aβ-42 peptides and amyloid binding alcohol
dehydrogenase. Proteomic analysis of the brain from these
mice showed that the Prx II level was higher in the AD mice
model [18]. However, another study reported that the
expression level of Prx I was higher in post-morten human
AD cortex tissue than in age-matched control [8]. In our
study, the expression level of Prx I was significantly higher
in Tg mice overexpressing Pen-2 gene compare to non-Tg
mice, while the level of Prx VI was the same between these
two groups. Therefore, our results suggested that Prx I may
be correlated with the pathological condition of AD.
In this study, we investigated the correlation between Prx
I and the pathogenesis of AD. These results showed that
the accumulation of Aβ pepetides induced the expression
of Prx I, but not Prx VI. Also, the overexpression of Prx I
by transfection induced an increase in NCT and APH-1
expression and a decrease in PS-2 and Pen-2 expression.
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